Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:alternativeTo |
gptkb:DTaP_vaccine
gptkb:Tdap_vaccine gptkb:DT_vaccine |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:boosterInterval |
every 10 years
|
| gptkbp:broadcastOn |
booster every 10 years after initial series
|
| gptkbp:contains |
diphtheria toxoid
tetanus toxoid |
| gptkbp:contraindication |
severe allergic reaction to previous dose
|
| gptkbp:excludes |
pertussis component
|
| gptkbp:fullName |
Tetanus and diphtheria vaccine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Td vaccine
|
| gptkbp:protectedBy |
diphtheria
tetanus |
| gptkbp:recommendation |
adolescents
adults |
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
fatigue pain at injection site |
| gptkbp:type |
toxoid vaccine
|
| gptkbp:usedIn |
gptkb:Canada
gptkb:Europe gptkb:United_States |
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:bfsParent |
gptkb:Tetanus_Vaccine
gptkb:Diphtheria_vaccine gptkb:Tetanus_toxoid |
| gptkbp:bfsLayer |
6
|